Access the full text.
Sign up today, get DeepDyve free for 14 days.
Nirav Patel, R. Doshi, R. Kalra, N. Bajaj, G. Arora, P. Arora (2018)
Costs of Transcatheter Aortic Valve Replacement: Implications of Proposed Medicare Cuts.JACC. Cardiovascular interventions, 11 6
A. Biviano, T. Nazif, J. Dizon, H. Garan, J. Fleitman, D. Hassan, S. Kapadia, V. Babaliaros, Ke Xu, R. Parvataneni, J. Rodés‐Cabau, W. Szeto, W. Fearon, D. Dvir, T. Dewey, Mathew Williams, M. Mack, J. Webb, D. Miller, Craig Smith, M. Leon, S. Kodali (2016)
Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) TrialCirculation: Cardiovascular Interventions, 9
Stortecky (2013)
Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation.Circ Cardiovasc Interv, 6
A. Walkey, R. Wiener, J. Ghobrial, L. Curtis, E. Benjamin (2011)
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.JAMA, 306 20
T. David (2003)
The American Association for Thoracic SurgeryThe Journal of Thoracic and Cardiovascular Surgery, 125
P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, B. Popescu, U. Schotten, B. putte, P. Vardas (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.European heart journal, 37 38
David Adams, J. Popma, M. Reardon, S. Yakubov, J. Coselli, G. Deeb, T. Gleason, M. Buchbinder, J. Hermiller, N. Kleiman, S. Chetcuti, J. Heiser, William Merhi, G. Zorn, P. Tadros, N. Robinson, G. Petrossian, G. Hughes, J. Harrison, J. Conte, Brijeshwar Maini, Mubashir Mumtaz, Sharla Chenoweth, J. Oh (2014)
Transcatheter aortic-valve replacement with a self-expanding prosthesis.The New England journal of medicine, 370 19
A. Furuta, N. Lellouche, G. Mouillet, T. Dhanjal, M. Gilard, M. Laskar, H. Eltchaninoff, J. Fajadet, B. Iung, P. Donzeau‐Gouge, P. Leprince, Alain Leuguerrier, A. Prat, J. Dubois-Randé, E. Teiger (2016)
Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.International journal of cardiology, 210
I. Amat-Santos, J. Rodés‐Cabau, M. Urena, R. Delarochelliére, D. Doyle, R. Bagur, J. Villeneuve, M. Côté, L. Nombela‐Franco, F. Philippon, P. Pibarot, E. Dumont (2012)
Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation.Journal of the American College of Cardiology, 59 2
P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, B. Popescu, U. Schotten, B. putte, P. Vardas, S. Agewall, J. Camm, G. Esquivias, W. Budts, S. Carerj, F. Casselman, A. Coca, R. Caterina, S. Deftereos, D. Dobrev, J. Ferro, G. Filippatos, D. Fitzsimons, B. Gorenek, M. Guenoun, S. Hohnloser, P. Kolh, G. Lip, A. Manolis, J. McMurray, P. Ponikowski, R. Rosenhek, F. Ruschitzka, I. Savelieva, Sanjay Sharma, P. Suwalski, J. Tamargo, C. Taylor, I. Gelder, A. Voors, S. Windecker, J. Zamorano, K. Zeppenfeld (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 11
S. Lubitz, S. Lubitz, Xiaoyan Yin, Henry Lin, Matthew Kolek, Gustav Smith, S. Trompet, M. Rienstra, N. Rost, Pedro Teixeira, P. Almgren, C. Anderson, C. Anderson, L. Chen, G. Engström, I. Ford, K. Furie, Xiuqing Guo, M. Larson, K. Lunetta, P. Macfarlane, B. Psaty, B. Psaty, E. Soliman, N. Sotoodehnia, D. Stott, K. Taylor, L. Weng, L. Weng, J. Yao, B. Geelhoed, N. Verweij, J. Siland, S. Kathiresan, S. Kathiresan, C. Roselli, D. Roden, P. Harst, D. Darbar, D. Darbar, J. Jukema, O. Melander, J. Rosand, J. Rosand, J. Rotter, S. Heckbert, S. Heckbert, P. Ellinor, P. Ellinor, Á. Alonso, E. Benjamin (2017)
Genetic Risk Prediction of Atrial FibrillationCirculation, 135
G. Tarantini, M. Mojoli, S. Windecker, O. Wendler, T. Lefévre, F. Saia, T. Walther, P. Rubino, A. Bartorelli, M. Napodano, A. D'Onofrio, G. Gerosa, S. Iliceto, A. Vahanian (2016)
Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.JACC. Cardiovascular interventions, 9 9
The case for the present-on-admission (POA) indicator
L. Chen, M. Chung, L. Allen, M. Ezekowitz, K. Furie, Pamela McCabe, P. Noseworthy, M. Perez, M. Turakhia (2018)
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity A Scientific Statement From the American Heart AssociationCirculation, 137
J. Heeringa, D. Kuip, A. Hofman, J. Kors, G. Herpen, B. Stricker, T. Stijnen, G. Lip, J. Witteman (2006)
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.European heart journal, 27 8
W. Mcintyre, S. Connolly, J. Healey (2018)
Atrial fibrillation occurring transiently with stressCurrent Opinion in Cardiology, 33
N. Hansson, E. Grove, H. Andersen, J. Leipsic, O. Mathiassen, J. Jensen, K. Jensen, P. Blanke, T. Leetmaa, M. Tang, L. Krusell, K. Klaaborg, E. Christiansen, K. Terp, C. Terkelsen, S. Poulsen, J. Webb, H. Bøtker, B. Nørgaard (2016)
Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications.Journal of the American College of Cardiology, 68 19
Craig Smith, M. Leon, M. Mack, D. Miller, J. Moses, L. Svensson, E. Tuzcu, J. Webb, G. Fontana, R. Makkar, Mathew Williams, T. Dewey, S. Kapadia, V. Babaliaros, V. Thourani, P. Corso, A. Pichard, J. Bavaria, H. Herrmann, J. Akin, W. Anderson, Duolao Wang, S. Pocock (2011)
Transcatheter versus surgical aortic-valve replacement in high-risk patients.The New England journal of medicine, 364 23
M. Reardon, N. Mieghem, J. Popma, N. Kleiman, L. Søndergaard, Mubashir Mumtaz, David Adams, G. Deeb, Brijeshwar Maini, H. Gada, S. Chetcuti, T. Gleason, J. Heiser, R. Lange, William Merhi, J. Oh, P. Olsen, N. Piazza, Mathew Williams, S. Windecker, S. Yakubov, E. Grube, R. Makkar, Joon Lee, J. Conte, E. Vang, H. Nguyen, Yanping Chang, Andrew Mugglin, P. Serruys, A. Kappetein (2017)
Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk PatientsThe New England Journal of Medicine, 376
L. Fleisher, K. Fleischmann, A. Auerbach, S. Barnason, J. Beckman, B. Bozkurt, V. Dávila-Román, M. Gerhard-Herman, T. Holly, Garvan Kane, J. Marine, M. Nelson, Crystal Spencer, Annemarie Thompson, H. Ting, B. Uretsky, D. Wijeysundera (2014)
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation, 130 24
G. Filardo, Cody Hamilton, B. Hamman, R. Hebeler, John Adams, P. Grayburn (2010)
New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery.The Annals of thoracic surgery, 90 2
G. Jong, Hung-Yi Chen, Shu-yi Li, Y. Liou (2014)
Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort studyHypertension Research, 37
G. Tarantini, M. Mojoli, M. Urena, A. Vahanian (2016)
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcomeEuropean Heart Journal, 38
Agency for Healthcare Research and Quality. HCUP methods series
Leon (2010)
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med, 363
I. Barbash, S. Minha, I. Ben‐dor, D. Dvir, R. Torguson, Muhammad Aly, E. Bond, L. Satler, A. Pichard, R. Waksman (2015)
Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions, 85
A. Sannino, R. Stoler, B. Lima, B. Lima, Molly Szerlip, A. Henry, R. Vallabhan, R. Kowal, David Brown, M. Mack, P. Grayburn, P. Grayburn (2016)
Frequency of and Prognostic Significance of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation.The American journal of cardiology, 118 10
T. Tanawuttiwat, Brian O'Neill, Mauricio Cohen, O. Chinthakanan, A. Heldman, C. Martinez, C. Alfonso, R. Mitrani, C. Macon, R. Carrillo, Donald Williams, W. O’Neill, R. Myerburg (2013)
New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches.Journal of the American College of Cardiology, 63 15
L. Nombela‐Franco, J. Webb, P. Jaegere, S. Toggweiler, R. Nuis, A. Dager, I. Amat-Santos, A. Cheung, J. Ye, R. Binder, R. Boon, N. Mieghem, L. Benítez, Sergio Perez, Javier López, J. Román, D. Doyle, R. Delarochelliére, M. Urena, J. Leipsic, E. Dumont, J. Rodés‐Cabau (2012)
Timing, Predictive Factors, and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve ImplantationCirculation, 126
S. Stortecky, L. Buellesfeld, P. Wenaweser, D. Heg, T. Pilgrim, A. Khattab, S. Gloekler, C. Huber, F. Nietlispach, B. Meier, P. Jüni, S. Windecker (2013)
Atrial Fibrillation and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve ImplantationCirculation: Cardiovascular Interventions, 6
R. Khera, Suveen Angraal, T. Couch, John Welsh, B. Nallamothu, S. Girotra, P. Chan, H. Krumholz (2017)
Adherence to Methodological Standards in Research Using the National Inpatient SampleJAMA, 318
Lior Yankelson, A. Steinvil, Liron Gershovitz, E. Leshem‐Rubinow, A. Furer, S. Viskin, G. Keren, S. Banai, A. Finkelstein (2014)
Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation.The American journal of cardiology, 114 12
Biviano (2016)
Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valve (PARTNER) trial.Circ Cardiovasc Interv, 9
M. Engelmann, J. Svendsen (2005)
Inflammation in the genesis and perpetuation of atrial fibrillation.European heart journal, 26 20
C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa, J. Cleveland, J. Conti, P. Ellinor, M. Ezekowitz, M. Field, K. Murray, R. Sacco, W. Stevenson, P. Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.Journal of the American College of Cardiology, 64 21
R. Nuis, N. Mieghem, C. Schultz, A. Moelker, R. Boon, R. Geuns, A. Lugt, P. Serruys, J. Rodés‐Cabau, R. Domburg, P. Koudstaal, P. Jaegere (2012)
Frequency and causes of stroke during or after transcatheter aortic valve implantation.The American journal of cardiology, 109 11
M. Leon, Craig Smith, M. Mack, M. Mack, R. Makkar, L. Svensson, S. Kodali, V. Thourani, M. Tuzcu, D. Miller, H. Herrmann, Darshan Doshi, D. Cohen, A. Pichard, S. Kapadia, T. Dewey, V. Babaliaros, W. Szeto, Mathew Williams, D. Kereiakes, A. Zajarías, K. Greason, B. Whisenant, R. Hodson, J. Moses, A. Trento, David Brown, W. Fearon, P. Pibarot, R. Hahn, W. Jaber, W. Anderson, Maria Alu, J. Webb (2016)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.The New England journal of medicine, 374 17
B. Carabello (2011)
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryCurrent Cardiology Reports, 13
Tanush Gupta, K. Goel, D. Kolte, S. Khera, P. Villablanca, W. Aronow, A. Bortnick, D. Slovut, C. Taub, J. Kizer, R. Pyo, J. Abbott, G. Fonarow, C. Rihal, Mario Garcia, Deepak Bhatt (2017)
Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.JACC. Cardiovascular interventions, 10 20
Steven Austin, Y. Wong, R. Uzzo, J. Beck, B. Egleston (2015)
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score WorkMedical Care, 53
K. Goel, Tanush Gupta, D. Kolte, S. Khera, G. Fonarow, Deepak Bhatt, Mandeep Singh, C. Rihal (2017)
Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United StatesJAMA Cardiology, 2
R. Khera, A. Pandey, Thomas Koshy, C. Ayers, B. Nallamothu, Sandeep Das, M. Drazner, M. Jessen, A. Kirtane, T. Gardner, J. Lemos, Deepak Bhatt, D. Kumbhani (2017)
Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United StatesJAMA Cardiology, 2
G. Frendl, Alissa Sodickson, M. Chung, A. Waldo, B. Gersh, J. Tisdale, H. Calkins, S. Aranki, T. Kaneko, S. Cassivi, Sidney Smith, D. Darbar, J. Wee, T. Waddell, D. Amar, D. Adler (2014)
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.The Journal of thoracic and cardiovascular surgery, 148 3
M. Mack, M. Leon, V. Thourani, R. Makkar, S. Kodali, M. Russo, S. Kapadia, C. Malaisrie, D. Cohen, P. Pibarot, J. Leipsic, R. Hahn, P. Blanke, Mathew Williams, J. McCabe, David Brown, V. Babaliaros, S. Goldman, W. Szeto, P. Généreux, A. Pershad, S. Pocock, Maria Alu, J. Webb, Craig Smith (2019)
Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk PatientsThe New England Journal of Medicine, 380
R. Makkar, G. Fontana, H. Jilaihawi, T. Chakravarty, K. Kofoed, O. Backer, F. Asch, C. Ruiz, N. Olsen, A. Trento, J. Friedman, D. Berman, W. Cheng, Mohammad Kashif, V. Jelnin, C. Kliger, Hongfei Guo, A. Pichard, N. Weissman, S. Kapadia, E. Manasse, Deepak Bhatt, M. Leon, L. Søndergaard (2015)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.The New England journal of medicine, 373 21
A. Maan, E. Heist, J. Passeri, I. Inglessis, Joshua Baker, L. Ptaszek, G. Vlahakes, J. Ruskin, I. Palacios, T. Sundt, M. Mansour (2015)
Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.The American journal of cardiology, 115 2
T. Jørgensen, H. Thyregod, J. Tarp, J. Svendsen, L. Søndergaard (2017)
Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.International journal of cardiology, 234
M. Mojoli, B. Gersh, Alberto Barioli, G. Masiero, P. Tellaroli, G. D’Amico, G. Tarantini (2017)
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.American heart journal, 192
Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. Overview of the state inpatient databases
Zakeih Chaker, V. Badhwar, Fahad Alqahtani, S. Aljohani, Chad. Zack, D. Holmes, C. Rihal, M. Alkhouli (2017)
Sex Differences in the Utilization and Outcomes of Surgical Aortic Valve Replacement for Severe Aortic StenosisJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6
A. Vora, Dadi Dai, Roland Matsuoka, J. Harrison, G. Hughes, M. Sherwood, J. Piccini, B. Bhardwaj, R. Lopes, D. Cohen, D. Holmes, V. Thourani, E. Peterson, A. Kirtane, S. Kapadia, S. Vemulapalli (2018)
Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.JACC. Cardiovascular interventions, 11 17
ImportanceData on the burden of new-onset atrial fibrillation after transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (AVR) is limited mostly to small series or post hoc analyses of clinical trials. ObjectivesTo evaluate the incidence of new-onset atrial fibrillation and assess the incidence of in-hospital mortality associated with new-onset atrial fibrillation after TAVI and AVR. Design, Setting, and ParticipantsIn this population-based observational study using the National Inpatient Sample and a validation cohort from the New York state inpatient database, the National Inpatient Sample was queried from January 1, 2012, to September 30, 2015, and the New York state inpatient database was queried from January 1, 2012, to December 31, 2014. Hospitalizations of adults undergoing TAVI or isolated AVR were examined. The incidence of in-hospital mortality across groups with new-onset atrial fibrillation was assessed in the National Inpatient Sample cohort using multivariable logistic regression modeling. Statistical analysis was conducted from August 20, 2018, to March 19, 2019. Main Outcomes and MeasuresThe primary outcome was the occurrence of new-onset atrial fibrillation, which was identified by excluding hospitalizations in which atrial fibrillation was present on admission. The secondary outcome was in-hospital mortality in TAVI and AVR hospitalizations with and without new-onset atrial fibrillation. ResultsA total of 48 715 TAVI hospitalizations (47.4% women and 52.6% men; mean [SD] age, 81.3 [8.1] years; 82.3% white) and 122 765 AVR hospitalizations (39.0% women and 61.0% men; mean [SD] age, 67.8 [12.0] years; 78.0% white) were identified. New-onset atrial fibrillation occurred in 50.4% of TAVI hospitalizations and 50.1% of AVR hospitalizations. In the multivariable-adjusted model, TAVI and AVR hospitalizations with new-onset atrial fibrillation had higher odds of in-hospital mortality compared with hospitalizations without new-onset atrial fibrillation (TAVI: odds ratio, 1.57; 95% CI, 1.21-2.04; and AVR: odds ratio, 1.36; 95% CI, 1.08-1.70). The results were then confirmed with the New York state inpatient database, which contains a present on arrival indicator. The incidence of new-onset atrial fibrillation was 14.1% (244 of 1736 hospitalizations) after TAVI and 30.6% (1573 of 5141 hospitalizations) after AVR in the New York state inpatient database. Conclusions and RelevanceIn this large nationwide study, a substantial burden of new-onset atrial fibrillation was observed after TAVI and AVR. The incidence of new-onset atrial fibrillation was higher after AVR than after TAVI in a patient-level state inpatient database.
JAMA Internal Medicine – American Medical Association
Published: Aug 3, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.